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Materials and Methods 
Unless otherwise stated, reactions were performed in flame-dried glassware under nitrogen 
atmosphere using dry, deoxygenated solvents (distilled or passed over a column of activated 
alumina). Reaction temperatures were controlled by an IKAmag temperature modulator. Thin 
layer chromatography (TLC) was performed using E. Merck silica gel 60 F254 precoated plates 
(0.25 mm) and visualized by UV fluorescence quenching. SiliaFlash P60 Academic Silica gel 
(particle size 0.040-0.063 mm) was used for flash chromatography. 1H and 13C NMR spectra 
were recorded either on a Bruker AV III HD spectrometer equipped with a Prodigy liquid 
nitrogen temperature cryoprobe (400 MHz and 101 MHz, respectively) or on a Varian Inova 
500 (500 MHz and 125 MHz, respectively) and are reported relative to Me4Si (δ 0.0). IR spectra 
were recorded on a Perkin Elmer Paragon 1000 Spectrometer and are reported in frequency of 
absorption (cm-1). Preparatory HPLC was performed using an Agilent 1100 Series HPLC 
utilizing a Zorbax XDB-C18 column purchased from Agilent Technologies. HRMS were 
acquired using an Agilent 6200 Series TOF with an Agilent G1978A Multimode source in 
electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI) or mixed (MM) 
ionization mode or with a JEOL JMS-600H in fast atom bombardment (FAB+). 
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Imide Synthesis and Characterization Data 
 
 
3-methyl-N-(3-methylbutanoyl)butanamide (S1): In air, H5IO6 (4.42 g, 19.4 mmol, 6.0 equiv), 
CrO3 (16.2 mg, 0.16 mmol, 5.0 mol %), and MeCN (46 mL) were sequentially added to a round 
bottom flask equipped with a magnetic stir bar. The reaction mixture was stirred for 30 minutes 
at ambient temperature, at which point acetic anhydride (1.8 mL, 19.4 mmol, 6.0 equiv) was 
added. The mixture was cooled to 0 °C, and S1 (553 mg, 3.23 mmol, 1.0 equiv) was added 
slowly. The resulting mixture was allowed to warm to ambient temperature over 12 h. The 
reaction was quenched with ice water and extracted with EtOAc (4 x 40 mL). The resulting 
organic layers were concentrated in vacuo and purified by column chromatography (20% 
EtOAc in hexanes) to afford S2 (89 mg, 15% yield) as a white solid; Rf = 0.15 (10% EtOAc in 
hexanes); 1H NMR (400 MHz, CDCl3) δ 8.72 (br s, 1H), 2.47 (d, J = 9.4, 4H), 2.14 (heptet, J = 
9.0 Hz, 2H), 0.98 (s, 12 H); 13C (101 MHz, CDCl3) δ 173.9, 46.3, 25.2, 22.4. IR (Neat Film, 
NaCl) 3272.4, 3170.7, 2957.7, 2871.5, 1728.6, 1505.7, 1466.8, 1386.4, 1367.0, 1294.4, 1246.8, 
1181.5, 1160.6, 1120.1, 1090.0 cm-1; HRMS (FAB+) m/z calc’d for C10H20NO2 [M+H]+: 
186.1494, found 186.1500. 
 
 
Methyl (2-phenylacetyl)carbamate (S5): In air, 2-phenylacetyl chloride (S3, 309.2 mg, 0.26 
mL, 2.00 mmol, 1.0 equiv), methyl carbamate (S4, 450.4 mg, 6.00 mmol, 3.0 equiv), and PhMe 
(10 mL) were added. The reaction vessel was heated to 80 °C for 12 h. The reaction was cooled 
to 23 °C, concentrated, and purified by column chromatography (10% EtOAc in hexanes) to 
afford S5 (34.1 mg, 9% yield) as white solid; Rf = 0.40 (50% EtOAc in hexanes); 1H NMR (500 
MHz, CDCl3) δ 7.48 (br s, 1H), 7.36–7.33 (m, 2H), 7.31–7.27 (m, 3H), 4.07 (s, 2H), 3.78 (s, 
3H); 13C (126 MHz, CDCl3) δ 152.0, 138.5, 133.3, 129.6, 128.6, 127.4, 110.0, 53.1. IR (Neat 
Film, NaCl) 3246.1, 3172.3, 3014.0, 2259.7, 1788.1, 1757.5, 1686.2, 1520.2, 1455.7, 1257.2, 
1216.1, 1192.1, 1144.1, 1049.9, 781.9, 705.3 cm-1; HRMS (ESI-APCI) m/z calc’d for 
C10H12NO3 [M+H]+: 194.0817, found 194.0817. 
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Aryl Ketoamide Synthesis and Characterization Data 
 
 
 
 
Representative Procedure for Acylamination 
A 2-dram vial equipped with a magnetic stir bar was charged with TBAT (144.7 mg, 0.268 
mmol, 2.0 equiv) and imide 10 (13.6 mg, 0.134 mmol, 1.0 equiv). The vial was purged with 
nitrogen, and PhMe (1.6 mL) was added via syringe followed by silyl triflate 1 (60.0 mg, 0.201 
mmol, 1.5 equiv). The vial was sealed and placed in an aluminum block preheated to 60 °C. The 
reaction mixture was stirred at this temperature for 16 h, then it was allowed to cool to 23 °C. 
The mixture was concentrated in vacuo and purified by column chromatography (10% EtOAc 
in hexanes) to afford 11 (23.6 mg, 89% yield) as a white solid. Characterization data match 
those previously reported;1 1H NMR (300 MHz, CDCl3) δ 11.70 (s, 1H), 8.74 (d, J = 8.6 Hz, 
1H), 7.90 (d, J = 8.2 Hz, 1H), 7.56 (dd, J = 7.3, 8.6 Hz, 1H), 7.12 (dd, J = 8.2, 7.3 Hz, 1H), 2.67 
(s, 3H), 2.23 (s, 3H). 
 
 
N-(2-propionylphenyl)propionamide (13a): Prepared according to the representative 
procedure using N-propionylpropionamide (17.3 mg, 0.134 mmol) and silyl triflate 1 (60.0 mg, 
0.201 mmol). The reaction was purified by column chromatography (10% EtOAc in hexanes) to 
afford 13a (24.0 mg, 88% yield) as a white solid. Characterization data match those previously 
reported.2 1H NMR (300 MHz, CDCl3) δ 11.78 (s, 1H), 8.78 (d, J = 9.0 Hz, 1H), 7.93 (d, J = 9.0 
Hz, 1H), 7.57–7.51 (m, 1H), 7.13–7.07 (m, 1H), 3.06 (q, J = 7.2 Hz, 2H), 2.50 (q, J = 7.6, 2H), 
1.31–1.20 (m, 6H). 
 
 
N-(2-benzoylphenyl)benzamide (13b): Prepared according to the representative procedure 
using N-benzoylbenzamide (30.2 mg, 0.134 mmol) and silyl triflate 1 (60.0 mg, 0.201 mmol). 
The reaction was purified by column chromatography (10% EtOAc in hexanes) to afford 13b 
(27.4 mg, 68% yield) as a white solid. Characterization data match those previously reported.3 
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1H NMR (400 MHz, CDCl3) δ 12.00 (s, 1H), 8.92 (d, J = 8.2 Hz, 1H), 8.11−8.08 (m, 2H), 7.74 
(t, J = 4.3 Hz, 2H), 7.66−7.59 (m, 3H), 7.56−7.49 (m, 5H), 7.14 (s, 1H). 
 
 
 
N-(2-isobutyrylphenyl)isobutyramide (13c): Prepared according to the representative 
procedure using N-isobutyrylisobutyramide (23.6 mg, 0.150 mmol) and silyl triflate 1 (67.1 mg, 
0.225 mmol). Purification was achieved by prep HPLC to afford 13c (27.3 mg, 78% yield) as a 
white solid; Rf = 0.4 (10% EtOAc in hexanes); 1H NMR (400 MHz, CDCl3) δ 11.80 (br s, 1H), 
8.79 (d, J = 6 Hz, 1H), 7.93 (d, J = 6 Hz, 1H), 7.53 (t, J = 4.5 Hz, 1H), 7.10 (t, J = 6 Hz, 1H), 
3.65 (sept, J = 6 Hz, 1H), 2.62 (sept, J = 6 Hz, 1H), 1.28 (d, J = 6 Hz, 6H), 1.23 (d, J = 6.0 Hz, 
6H); 13C (101 MHz, CDCl3) δ 209.2, 176.6, 141.7, 134.8, 130.6, 122.2, 121.1, 120.7, 37.6, 36.3, 
19.6 (2 unresolved signals); IR (Neat Film, NaCl) 3251.4, 2970.8, 2903.3, 2872.9, 1700.1, 
1653.0, 1604.8, 1583.4, 1521.7, 1517.1, 1467.7, 1450.3, 1383.3, 1356.5, 1350.9, 1301.9, 
1239.0, 1211.6, 1157.4, 1099.6, 1083.7, 976.8, 755.1 cm-1; HRMS (MM: ESI-APCI) m/z calc’d 
for C14H20NO2 [M+H]+: 234.1489, found: 234.1490. 
 
 
3-methyl-N-(2-(3-methylbutanoyl)phenyl)butanamide (13d): Prepared according to the 
representative procedure using imide S2 (37.1 mg, 0.200 mmol) and silyl triflate 1 (89.5 mg, 
0.300 mmol). Purification was achieved by prep HPLC to afford 13d (41.3 mg, 79% yield) as a 
white solid. Rf = 0.30 (10% EtOAc in hexanes); 1H NMR (400 MHz, CDCl3) δ 11.73 (br s, 1H), 
8.77 (d, J = 1.6 Hz, 1H), 7.90 (d, J = 10.8 Hz, 1H), 7.53 (t, J = 9.8 Hz, 1H), 7.10 (t, J = 9.8 Hz, 
1H), 2.88 (d, J = 9.2 Hz, 2H), 2.33–2.19 (m, 4H), 1.03–0.99 (m, 12H); 13C (126 MHz, CDCl3) 
205.0, 172.1, 141.0, 134.9, 130.4, 122.2, 121.92, 120.9, 49.0, 48.1, 26.3, 25.6, 22.7, 22.5. IR 
(Neat Film, NaCl) 3255.4, 2957.6, 2929.9, 2870.7, 1698.8, 1651.9, 1583.5, 1520.0, 1450.7, 
1386.2, 1366.0, 1298.9, 1281.3, 1258.1, 1201.8, 1163.5, 1114.3, 1003.9, 947.5, 754.1 cm-1; 
HRMS (MM: ESI-APCI) m/z calc’d for C16H24NO2 [M+H]+: 262.1802, found: 262.1804. 
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Methyl 2-(2-phenylacetamido)benzoate (13e): Prepared according to the representative 
procedure using imide S5 (25.9 mg, 0.134 mmol) and silyl triflate 1 (60.0 mg, 0.201 mmol). 
The reaction was purified by column chromatography (10% EtOAc in hexanes) to afford 13e 
(8.7 mg, 24% yield) as a white solid. Rf = 0.30 (10% EtOAc in hexanes); 1H NMR (400 MHz, 
CDCl3) δ 11.04 (br s, 1H), 8.70 (dd, J = 8.0 Hz, 1.2 Hz, 1H), 7.99 (dd, J = 8.0, 1.2 Hz, 1H), 
7.54–7.49 (m, 1H), 7.41–7.28 (m, 5H), 7.08–7.01 (m, 1H), 3.86 (s, 3H), 3.76 (s, 2H); 13C (101 
MHz, CDCl3) 170.0, 168.5, 141.4, 134.6, 134.4, 130.8, 129.5, 129.3, 128.9, 127.3, 122.6, 120.4, 
52.3, 45.9. IR (Neat Film, NaCl) 2917.9, 1687.6, 1588.4, 1523.0, 1448.6, 1309.3, 1263.3, 
1193.6, 1088.9, 756.5 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C16H15NO3 [M+H]+: 
270.1125, found: 270.1129. 
 
 
2-Acetylphenyl acetate (13g): Prepared according to the representative procedure using acetic 
anhydride (13.7 mg, 0.134 mmol) and silyl triflate 1 (60.0 mg, 0.201 mmol). The reaction was 
purified by column chromatography (10% EtOAc in hexanes) to afford 13g (12.8 mg, 54% 
yield) as a white solid. Characterization data match those previously reported.4  1H NMR (300 
MHz, CDCl3) δ 7.78 (d, J = 7.8 Hz, 1H), 7.50 (t, J = 7.7 Hz, 1H), 7.28 (t, J = 7.6 Hz, 1H), 7.10 
(d, J = 8.0 Hz, 1H), 2.52 (s, 3H), 2.32 (s, 3H). 
 
 
N-(2-acetyl-4,5-dimethylphenyl)acetamide (15a): Prepared according to the representative 
procedure using imide 10 (8.4 mg, 0.083 mmol) and silyl triflate 14a (40.5 mg, 0.124 mmol). 
Purified by column chromatography (10% EtOAc in hexanes) to afford 15a (6.5 mg, 31% yield) 
as a white solid. Rf = 0.15 (10% EtOAc in hexanes); 1H NMR (400 MHz, CDCl3) δ 11.63 (br s, 
1H), 8.53 (s, 1H), 7.61 (s, 1H), 2.63 (s, 3H), 2.31 (s, 3H), 2.26 (s, 3H), 2.21 (s, 3H); 13C (101 
MHz, CDCl3) δ 202.4, 169.4, 145.3, 139.1, 132.4, 130.6, 121.5, 119.8, 28.6, 25.6, 20.6, 19.4. IR 
(Neat Film, NaCl) 3238.4, 2917.3, 1692.5, 1643.4, 1579.0, 1514.1, 1450.2, 1397.3, 1353.6, 
OMe
O
NH
O Bn
13e
Me
O
O
O Me
13g
MeO
NHMe
Me
O
Me
15a
Wright, Haley, LaPointe, and Stoltz  Supporting Information 
 S6 
1286.8, 1270.0, 1235.1, 1018.7, 876.4, 758.9, 659.3 cm-1; HRMS (MM: ESI-APCI) m/z calc’d 
for C12H16NO2 [M+H]+: 206.1176, found: 206.1171. 
 
 
 
N-(3-acetylnaphthalen-2-yl)acetamide (15b): Prepared according to the representative 
procedure using imide 10 (29.0 mg, 0.287 mmol) and silyl triflate 14b (150.0 mg, 0.431 mmol). 
Purification was achieved by prep HPLC to afford 15b (28.7 mg, 44% yield) as a white solid; Rf 
= 0.35 (30% EtOAc in hexanes); 1H NMR (400 MHz, CDCl3) δ 11.50 (br s, 1H), 9.12, (s, 1H), 
8.44 (s, 1H), 7.83 (d, J = 9.0 Hz, 2H), 7.57 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 2.80 (s, 
3H), 2.27 (s, 3H); 13C (101 MHz, CDCl3) 203.0, 169.3, 136.7, 136.1, 134.3, 129.7, 128.9, 128.2, 
127.7, 125.6, 122.7, 117.7, 28.7, 25.6; IR (Neat Film, NaCl) 3217.8, 1682.2, 1654.4, 1577.0, 
1546.1, 1480.7, 1437.2, 1352.5, 1386.4, 1286.3, 1277.9, 1203.7, 1148.0, 1020.5, 953.6, 885.1, 
742.1, 656.2 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C14H14NO2 [M+H]+: 228.1019, 
found: 228.1022. 
 
 
N-(6-acetylbenzo[d][1,3]dioxol-5-yl)acetamide (15c): Prepared according to the the 
representative procedure using imide 10 (20.4 mg, 0.201 mmol) and silyl triflate 14c (103.4 mg, 
0.302 mmol). Purification was achieved by prep HPLC to afford 15c (28.9 mg, 65% yield) as a 
white solid; Rf = 0.55 (50% EtOAc in hexanes); 1H NMR (400 MHz, CDCl3) δ 12.08 (br s, 1H), 
8.37 (s, 1H), 7.25 (s, 1H), 6.02 (s, 2H), 2.57 (s, 3H), 2.20 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 
200.6, 169.5, 152.9, 142.4, 139.3, 115.1, 109.6, 102.1, 101.5, 28.8, 25.6. IR (Neat Film, NaCl) 
2916.7, 1692.6, 1611.8, 1502.7, 1483.5, 1433.8, 1370.2, 1342.5, 1243.2, 1178.9, 1118.8, 
1044.8, 927.0 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C11H12NO4 [M+H]+: 222.0761, 
found: 222.0766. 
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N-(2-acetyl-3-methoxyphenol)acetamide (15d): Prepared according to the representative 
procedure using imide 10 (13.6 mg, 0.134 mmol) and silyl triflate 14d (66.0 mg, 0.201 mmol). 
The reaction was purified by column chromatography (10% EtOAc in hexanes) to afford 15d 
(13.0 mg, 47% yield) as a white solid; Rf = 0.20 (20% EtOAc in hexanes); 1H NMR (500 MHz, 
CDCl3) δ 10.49 (s, 1H), 8.07 (d, J = 8.3 Hz, 1H), 7.40 (td, J = 8.4, 0.5 Hz, 1H), 6.69 (dd, J = 
8.4, 0.9 Hz, 1H), 2.57 (s, 3H), 3.90 (s, 3H), 2.61 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 204.6, 
169.2, 160.0, 139.2, 133.7, 116.5, 114.0, 106.2, 55.8, 33.7, 25.5; IR (Neat Film, NaCl) 3086.8, 
2947.7, 1698.6, 1639.6, 1634.0, 1528.8, 1470.6, 1403.5, 1273.1, 1243.4, 1195.9, 1093.2, 
1017.3, 967.4, 802.3, 735.2, 610.8 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C11H14NO3 
[M+H]+: 262.1802, found: 262.1804. 
 
Quinolone Synthesis and Characterization Data 
 
Representative Procedure for Quinolone Synthesis 
A 2-dram vial equipped with a magnetic stir bar was charged with TBAT (144.7 mg, 0.268 
mmol, 2.0 equiv) and imide 10 (13.6 mg, 0.134 mmol, 1.0 equiv). The vial was purged with 
nitrogen, and PhMe (1.6 mL) was added via syringe followed by silyl triflate 1 (60.0 mg, 0.201 
mmol, 1.5 equiv). The vial was sealed and placed in an aluminum block preheated to 60 °C. The 
reaction mixture was stirred at this temperature for 16 h, then it was allowed to cool to 23 °C. 
The mixture was concentrated in vacuo and then charged with dioxane (1.6 mL), KOH (22.6 
mg, 0.402 mmol, 3.0 equiv), and 18-crown-6 (106.3 mg, 0.402 mmol, 3.0 equiv). The reaction 
vial was sealed and heated to 110 °C and stirred for 2 h. The reaction was allowed to cool, 
diluted with CH2Cl2 (10 mL), neutralized to pH ~7, and washed with brine (10 mL). The layers 
were separated, and the aqueous layer was back extracted with CH2Cl2 (2 x 10 mL). The 
combined organic layers were dried (Na2SO4), concentrated, and purified by column 
chromatography (CH2Cl2 to 5% MeOH in CH2Cl2) to provide 16a (15.1 mg, 71% yield) as a 
yellow solid.  Characterization data match those previously reported.5  1H NMR (400 MHz, 
CDCl3) δ 12.04 (s, 1H), 7.79 (d, J = 10.8 Hz, 1H), 7.65–7.62 (m, 2H), 7.40–7.36 (m, 1H), 6.74 
(s, 1H), 2.61 (d, J = 1.4 Hz, 3H). 
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6,8-Dimethoxy-3-methylnaphthalen-1–(4H)-one (16b): Prepared according to the 
representative procedure using imide 10 (13.6 mg, 0.134 mmol) and 3,5-dimethoxy-2-
(trimethylsilyl)phenyl trifluoromethanesulfonate (S2, 66.0 mg, 0.201 mmol) to provide 
quinolone 16b (11.8 mg, 40% yield) as a brown solid. Characterization data match those 
previously reported.6  1H NMR (400 MHz, CDCl3) δ 7.08 (s, 1H), 6.75 (s, 1H), 6.74 (s, 1H), 
6.24–6.23 (m, 1H), 3.78 (s, 6H), 2.17 (s, 3H). 
 
 
8-Methoxy-3-methylnaphthalen-1–(4H)-one (16c): Prepared according to the representative 
procedure using imide 10 (13.6 mg, 0.134 mmol) and silyl triflate 13d (66.0 mg, 0.201 mmol) 
to provide quinolone 16c (10.6 mg, 42% yield) as a beige solid. Rf = 0.35 (10% MeOH in 
CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.29–7.27 (m, 1H), 7.21 (t, J = 8.2, 1H), 7.11 (br s, 
1H), 6.95 (d, J = 8.0 Hz, 1H), 6.67 (dd, J = 12.0, 11.2 Hz, 1H), 3.81 (s, 3H), 2.18 (s, 3H); 13C 
(126 MHz, CDCl3) 168.2, 160.2, 139.1, 134.8, 129.7, 111.8, 110.1, 105.6, 100.0 55.3, 24.8. IR 
(Neat Film, NaCl) 2920.7, 1664.8, 1598.3, 1548.7, 1492.8, 1425.9, 1369.9, 1252.6, 1156.1, 
1044.1, 775.1 cm-1; HRMS (MM: ESI-APCI) m/z calc’d for C11H12NO2 [M+H]+: 190.0863, 
found: 190.0866. 
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Preparatory HPLC Conditions 
 
 
 
Entry Product Conditions Retention Time (min)
1
2
3
4
HPLC
Zorbax XDB-C18 column
40% to 80% MeCN in H2O
15 min, 30.0 mL/min
HPLC
Zorbax XDB-C18 column
40% to 80% MeCN in H2O
20 min, 30.0 mL/min
HPLC
Zorbax XDB-C18 column
20% to 60% MeCN in H2O
15 min, 30.0 mL/min
HPLC
Zorbax XDB-C18 column
20% to 60% MeCN in H2O
15 min, 30.0 mL/min
Me
O
NH
O Me
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O
O
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14.36
17.35
12.75
13.90
5
HPLC
Zorbax XDB-C18 column
0% to 80% MeCN in H2O 
10 min, 15 mL/min
9.79
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Infrared spectrum (Thin Film, NaCl) of compound S2. 
 
13C NMR (101 MHz, CDCl3) of compound S2. 
 
Wright, Haley, LaPointe, and Stoltz  Supporting Information 
 S13 
Ph
H N
O
OM
e
O
S5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 H
 N
M
R
 (4
00
 M
H
z,
 C
D
C
l 3)
 o
f c
om
po
un
d 
S5
. 
 
Wright, Haley, LaPointe, and Stoltz  Supporting Information 
 S14 
Infrared spectrum (Thin Film, NaCl) of compound S5. 
 
13C NMR (101 MHz, CDCl3) of compound S5. 
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13C NMR (101 MHz, CDCl3) of compound 13c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 13c. 
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 S18 
13C NMR (101 MHz, CDCl3) of compound 13d. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infrared spectrum (Thin Film, NaCl) of compound 13d. 
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 S20 
13C NMR (101 MHz, CDCl3) of compound 13e. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infrared spectrum (Thin Film, NaCl) of compound 13e. 
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13C NMR (101 MHz, CDCl3) of compound 15a. 
 
Infrared spectrum (Thin Film, NaCl) of compound 15a. 
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13C NMR (101 MHz, CDCl3) of compound 15b. 
 
Infrared spectrum (Thin Film, NaCl) of compound 15b. 
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13C NMR (101 MHz, CDCl3) of compound 15c. 
 
Infrared spectrum (Thin Film, NaCl) of compound 15c. 
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Infrared spectrum (Thin Film, NaCl) of compound 15d. 
 
13C NMR (101 MHz, CDCl3) of compound 15d. 
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 S30 
Infrared spectrum (Thin Film, NaCl) of compound 16c. 
 
13C NMR (101 MHz, CDCl3) of compound 16c. 
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